Researchers at the National Cancer Institute have developed an AI tool, PERCEPTION, that predicts patient responses to cancer treatment drugs using individual tumor cells. This approach provides better resolution data by utilizing single-cell RNA sequencing. The tool showed promise in clinical trials for myeloma and breast cancer by ranking drug combinations based on individual tumor cell responses. The NIH is investing in AI for early screening for autism and predicting PTSD following childbirth. In the life sciences sector, AI is being used for drug discovery, with companies like AION Labs producing AI-enabled drug discovery companies. These advancements aim to improve personalized medicine and enhance cancer screening techniques.
Source link
NIH develops AI tool to better pair cancer patients with drugs
